Luc Paquet

Luc has worked in the life sciences industry for over 25 years, in both academic and corporate environments, leading research teams, managing technology portfolios, and contributing to business strategy. He became CEO of Immune Biosolutions in November 2021, after serving as CEO of Univalor and Transfertech Sherbrooke. Luc played a key role in the biotechnology industry for over 10 years, converting new inventions into viable clinical candidates. He holds a PhD from the Université de Montréal and served as a post-doctoral fellow at Johns Hopkins University. Luc is known for his expertise in the life sciences industry and his commitment to innovation and growth.